Sunday, September 13, 2026

Donald Trump’s Surprising 107,000 USD Pension: How His Hollywood Cameos Pay Off

Trump earned over $64,000 in pension payments from SAG and AFTRA despite losing union membership after the Capitol riot.

Spider-Man: Brand New Day Breaks Records with 360 Million USD Opening – What’s Next for the MCU?

Spider-Man: Brand New Day attracted 4 million viewers in just seven days, showcasing its massive popularity.

Hanwha Achieves Top CDP Climate Rating, Upgraded to Leadership A

Hanwha Group achieved the highest Leadership A rating in the 2024 Climate Change Response Assessment by CDP, highlighting its climate initiatives.

Tag: business

How Huons Global is Transforming the Middle East Aesthetic Market with Innovative Products

Huons Group targets the Middle East market by consolidating its aesthetic products, including fillers and botulinum toxin.

GCCL Expands Global Partnerships at ABP 2026: Insights into Asia-Pacific Biotech Growth

GCCL, a global clinical trial specimen analysis firm, expanded its collaboration at the Asia Bio Partnering Forum 2026 in Singapore.

Samsung SDS Joins OpenAI’s Daybreak: A Game-Changer in Cybersecurity for 2026

Samsung SDS joins OpenAI's top-tier AI model program Daybreak to enhance its cybersecurity business, marking a first for domestic firms.

Techwing Secures 9.1 Billion KRW Semiconductor Equipment Deal with Micron India: What This Means for the Future

Techwing signs a supply contract worth 9.184 billion KRW with Micron's India unit, expanding its delivery regions after Malaysia.

Celtrion’s Steqeyma Seizes 16% Market Share in the U.S.: What’s Next for This Autoimmune Treatment?

Celltrion's autoimmune drug Steqeyma surpasses 16% market share in the U.S., accelerating prescription growth and expansion.

Yuhan Corp. Signs $874 Million API Supply Deal With Global Pharmaceutical Company

Yuhan Corp. has secured a long-term active pharmaceutical ingredient supply contract worth $874 million with a global pharmaceutical company, expanding its overseas export business.

EverEx’s MORA Solutions: Revolutionizing Musculoskeletal Care with AI in 2026

EverEx, a digital healthcare company, accelerates expansion with strategic investments from domestic pharma and tech firms.

Discover Daewoong Alliance: How Digital Healthcare is Transforming Patient Care in 2026

Daewoong Pharmaceutical accelerates business expansion by collaborating with domestic digital healthcare firms using medical data and AI.

K-Beauty Revolution: How Korean Medical Aesthetic Devices Are Dominating Global Markets

South Korea's skin beauty medical device companies are continuing to grow, focusing on the overseas market.

Neurophet Partners with Elevate Clinic: How AI is Transforming Brain Injury Diagnosis in the US

Neurophet signs supply contracts with Elevate Clinic for Neurophet Aqua and Neurofit Aqua AD Plus in the U.S. market.

HLB Group’s New Cancer Drug Lirapegrafinib: What to Expect from FDA Approval on September 25?

HLB Group's drug development business is set to achieve key clinical and approval milestones in the second half of this year.

SK Biopharmaceuticals Introduces Opacalim: Aiming for a 2029 U.S. Launch of an Innovative Epilepsy Treatment

Opacalim licensing marks not an end, but a new beginning for opportunities and growth in the industry.

How DongKoo Bio & Pharma Maintains Its Dermatology Dominance While Expanding into New Fields

DongKoo Bio & Pharma expands its business into specialized medicine markets, leveraging its prescription competitiveness in dermatology and urology.

LG Chem Unveils Advanced Semiconductor Solutions at SEMICON Taiwan 2026: What to Expect?

LG Chem joins SEMICON Taiwan 2026 to secure semiconductor clients and expand business collaborations.

Top News

- Our Sponsors Ad -

Follow us